Forum pracy nad projektem wskrzeszenia The Forge

[yoylqnqvwb]

,[link widoczny dla zalogowanych]
Progress in fulminant hepatitis


, Steroids, plasma exchange and filtration technologies, as the role of FVH in just as non-viral FHF disappointing. In recent years,[link widoczny dla zalogowanych], people hepatocyte growth factor (HGF) showed great interest. Since HGF in vivo on the regeneration of liver cells for a specific rejection, the clinical application of HGF treatment FVH an attractive prospect. There is an exciting report that Hanison's so. failure incidence and mortality of FVH suggesting that the drug could be used to support therapy as a treatment charge bashing. is expected to soon be seen in the randomized and controlled therapy study report. prostaglandin role in the effective treatment of FHF caused the same attention. FHF patients on cardiopulmonary bypass in the course of treatment. forefront of the gap element used initially as a platelet protective agent was later used to improve the microcirculation FHF. Sinclair's, etc. prostaglandin E (PGE.) clinical trials of treatment, the results of 17 patients in 12 clinical and biochemical detection of significant change general,[link widoczny dla zalogowanych], overall survival was 71. However, other studies failed to obtain the non-control study with consistent results. FVH specific treatment specific treatment is antiviral therapy. acyclovir has been successfully used in the treatment of herpes viral hepatitis. Acyclovir is also used to treat CMV and EBV of FVH. interferon on chronic B type and the treatment of hepatitis C has attracted attention, but the therapeutic value of their information on the FVH is still less recent reports from Israel, 5 FVH patients with a-interferon treatment, the condition improved markedly , 3 cases without serious side effects. This seems to suggest interference tangled on the FHF is safe and effective, but the number of cases is still small. People are very concerned about the side effects of interferon, including liver damage, fever,[link widoczny dla zalogowanych], white blood cells and thrombocytopenia and central nervous system toxicity. Because increased permeability of blood-brain barrier in patients with FHF, FVH liver transplantation can improve the prognosis of patients, the survival rate was 55 ~ 75 It is worth noting that the judge should first establish the prognosis of fulminant hepatitis, and then based on these indicators to know whether a patient has an emergency indication for liver transplantation. ● Covent t1. WrightTL. etaLAnnInternMed. {115.11 -12 1991. LngTJ. eta1. Gastroe ~ terology. 1999 ~ 104I5563 · YoshiblM · etal · Hepato] ojp], 1994,19. 8294. WuJc. eta1. p'0Iogy, 1994.19-2365.1ViasAtetaIHe. relay. 1990 ~ Iil10626Ashe ~ LV $. Feud aI. JMedV collapse) I_】 990 | 31.2267. K [elnNAtn. Crastfomnter ~ [ogy. 1991 100.2398. HibbsJR. eta1JAMA. 3992} 267l20519. LeeWM. et Ⅱ I. NEng [JMed. 1993I3 Peng 166,210. HarrmonPM · eta】. NEnJMed_1992I324'IB62lI. sindahS, etat. JC11nImve ~ t. 1999,84 I106312. ShelnerP, et, and I-HepJtoloJW, 1992j160: pp1)-884Ia. fs,[link widoczny dla zalogowanych], et spit Lt ~ et, 19IjI59214. KstoM. eta1. Hepatology, 1992I15I106015.1watsukiS. eta1. Trsnsp] ~ tPr0e. 1989121I2431i Man nSightettiTranspLant Dan ∞,】 § 9. j22I1505 (Received 951I28)